Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9502771.0Aexternal-prioritypatent/GB9502771D0/en
Priority claimed from GBGB9513505.9Aexternal-prioritypatent/GB9513505D0/en
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of MX9705757ApublicationCriticalpatent/MX9705757A/en
Publication of MXPA97005757ApublicationCriticalpatent/MXPA97005757A/en
The elF-5A mutant proteins are described which are normally devoid of substantial eIF-5A activity, and which inhibit Rev function, and thus possess an inhibitory phenotype with respect to Rev function, and genes or DNA sequences or cDNAs that code for the same
Claims (1)
lexion.
MXPA/A/1997/005757A1995-02-131997-07-30Mutants (eif-5a) of the eucarianic factor 5a iniciac
MXPA97005757A
(en)